Predictmedix Stock News

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has said new artificial intelligence (AI)-powered screening technology will make its Safe Entry stations able to read blood pressure, adding to its existing a

 Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare Operations Toronto, Ontario - March 30, 2023 -- InvestorsHub NewsWire -- Predictmedix Inc. ("Predictmedix" or the "Company") (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), today announced a purchase order from one of the largest Government hospital groups in I...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) said it has received a purchase order for its artificial intelligence (AI)-powered Safe Entry Stations from MGM Healthcare, one of the largest government hosp

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has noted that its AI-powered technology, powering the Safe Entry Station was featured in a major Indonesian newspaper on March 27, confirming the effecti

Predictmedix Inc, a provider of health screening solutions powered by artificial intelligence (AI), has announced the expansion of its non-invasive impairment detection technology for vertical-specifi

 Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening  Toronto, Ontario - March 21, 2023 - InvestorsHub NewsWire -- Predictmedix Inc. ("Predictmedix" or the "Company") (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that the US Patent Office has granted a patent for its AI-powered technology (United St...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) announced that the US Patent Office has granted the company a patent (United States Patent Application Number: 16/892,369) for its artificial intelligence (AI

 Predictmedix Announces Production of AI-Powered Mobile Application to Detect Impairment from Alcohol and Cannabis Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcohol Predictmedix's screening to identify impairment takes less than 30 seconds  The mobile application, powered by AI algorithms currently being utilized in Safe Entry will be accompanied by a "mini" multi-spectral imaging camera resulting in a portable non-...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced the production of its AI-Powered mobile app in conjunction with a portable multi-spectral imaging camera to non-invasively detect impairment fro

 Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix's Safe Entry for regulatory approval listed as a 'Medical Device' Medical device classification allows Predictmedix to commercialize Safe Entry at scale in Indonesia Third-party clinical validation yet another milestone for Predictmedix's AI-Powered screen...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced the completion of a 1,600-person clinical study at a prominent University in Indonesia to validate the company's AI-powered non-invasive screen

Predictmedix Announces a Purchase Order for Safe Entry's Fit for Duty Screening in the Defence Sector   DefSpace, a global platform for Defence, Space and Aerospace will lease four Safe Entry Stations over four-year term primarily utilizing Safe Entry's impairment detection screening   Each of the four Safe Entry Station's to generate $2500 per month in recurring revenue for an initial four-year term, approximating a total of $500,000  ...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced a purchase agreement with Defspace, an India-based global platform for defence, space and aerospace, for the company's Safe Entry's Fit for Duty

    Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare     Toronto, Ontario, February 15, 2023 -- InvestorsHub NewsWire -- Predictmedix Inc. ("Predictmedix" or the "Company") (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced pivotal clini...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) said its AI-powered Safe Entry Stations, which accurately screen for various physiological conditions non-invasively, have received pivotal clinical validatio